Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Peptides|September 12, 2006
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studiesRaffaella Vergura, Elena Valenti, Christopher P Hebbes, et al.Bioorganic & Medicinal Chemistry|May 11, 2007
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acidsMarika Arduin, Barbara Spagnolo, Girolamo Calò, et al.Bioorganic & Medicinal Chemistry|June 17, 2009
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamideClaudio Trapella, Carmela Fischetti, Michela Pela', et al.British Journal of Pharmacology|May 16, 2002
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptorGirolamo Calo, Anna Rizzi, Daniela Rizzi, et al.Peptides|December 11, 2007
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonistRaffaella Vergura, Gianfranco Balboni, Barbara Spagnolo, et al.Bioorganic & Medicinal Chemistry|October 6, 2005
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonistClaudio Trapella, Remo Guerrini, Laura Piccagli, et al.Journal of Medicinal Chemistry|March 4, 2005
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligandsRemo Guerrini, Girolamo Caló, David G Lambert, et al.The Journal of Biological Chemistry|May 25, 2006
Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activationAdelheid L Roth, Erika Marzola, Anna Rizzi, et al.Circulation|January 24, 2002
Targeting kinin B(1) receptor for therapeutic neovascularizationCostanza Emanueli, Maria Bonaria Salis, Tiziana Stacca, et al.The Journal of Pharmacology and Experimental Therapeutics|March 3, 2007
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studiesBarbara Spagnolo, Giacomo Carrà, Martina Fantin, et al.Pageof 8